It has been previously reported in an ovarian cancer patient of European ancestry in The Cancer Genome Atlas and showed a neutral impact on the BRCA1 function in a cell-based homology-directed recombination assay [47]. This evidence concerns the gene BRCA1 and ovarian carcinoma.